Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotrophic factor receptors are a group of cell surface proteins that mediate the actions of neurotrophic factors—peptides essential for neuron survival, development, function, and plasticity. The best-characterized members are the tropomyosin-related kinases—TrkA/NTRK1 binds nerve growth factor (NGF), TrkB/NTRK2 binds brain-derived neurotrophic factor (BDNF) and NT4/5, while TrkC/NTRK3 binds NT3—and the low-affinity p75 neurotrophin receptor which can bind all classical neurotrophins but mediates distinct cellular responses including apoptosis under certain conditions. These receptors play critical roles during development by regulating neuronal number through survival/death decisions and continue into adulthood where they modulate synaptic function. Aberrant activation via mutation/fusion events drives tumorigenesis in some cancers; conversely loss-of-function contributes to degeneration seen in diseases like Alzheimer's disease. Both small molecule inhibitors targeting oncogenic fusion proteins and protein-based therapies aiming at neural repair/regeneration have been developed against this target class.
Drugs may act as antagonists/inhibitors of tyrosine kinase activity to block oncogenic signaling in tumors with NTRK gene fusions; some experimental agents act as agonists to promote neuronal survival in degenerative diseases by mimicking endogenous ligands like NGF or BDNF
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophic factor receptor (No single abbreviation; common ones include TrkA, TrkB, TrkC, and p75NTR).